carbamates has been researched along with Epilepsy, Complex Partial in 2 studies
Epilepsy, Complex Partial: A disorder characterized by recurrent partial seizures marked by impairment of cognition. During the seizure the individual may experience a wide variety of psychic phenomenon including formed hallucinations, illusions, deja vu, intense emotional feelings, confusion, and spatial disorientation. Focal motor activity, sensory alterations and AUTOMATISM may also occur. Complex partial seizures often originate from foci in one or both temporal lobes. The etiology may be idiopathic (cryptogenic partial complex epilepsy) or occur as a secondary manifestation of a focal cortical lesion (symptomatic partial complex epilepsy). (From Adams et al., Principles of Neurology, 6th ed, pp317-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-five Sprague-Dawley rats were subjected to lithium-pilocarpine status epilepticus." | 3.80 | Attention and executive functions in a rat model of chronic epilepsy. ( Akimana, G; Barbelivien, A; Cassel, JC; Cosquer, B; Faure, JB; Ferrandon, A; Herbeaux, K; Koning, E; Marques-Carneiro, JE; Nehlig, A, 2014) |
| "Central nervous system effects are predominant within the adverse event profiles of both ezogabine and perampanel." | 2.49 | Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel. ( Burke, RA; Faulkner, MA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faulkner, MA | 1 |
| Burke, RA | 1 |
| Faure, JB | 1 |
| Marques-Carneiro, JE | 1 |
| Akimana, G | 1 |
| Cosquer, B | 1 |
| Ferrandon, A | 1 |
| Herbeaux, K | 1 |
| Koning, E | 1 |
| Barbelivien, A | 1 |
| Nehlig, A | 1 |
| Cassel, JC | 1 |
1 review available for carbamates and Epilepsy, Complex Partial
| Article | Year |
|---|---|
Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.
Topics: Anticonvulsants; Carbamates; Drug Monitoring; Drug Resistance; Epilepsy, Complex Partial; Humans; Ni | 2013 |
1 other study available for carbamates and Epilepsy, Complex Partial
| Article | Year |
|---|---|
Attention and executive functions in a rat model of chronic epilepsy.
Topics: Animals; Anticonvulsants; Attention; Brain; Brain Mapping; Carbamates; Cell Count; Disease Models, A | 2014 |